1.41
price down icon16.57%   -0.28
pre-market  Vorhandelsmarkt:  1.42   0.01   +0.71%
loading

Finanzdaten der Tharimmune Inc-Aktie (THAR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-09-30
Periodenlänge 3 Monate 3 Monate
Revenues
-
-
Operating Expenses
27.22%
2.3473
1.8451
Interest Income/Expense
0.0047
-
Operating Income/Loss
27.22%
-2.3473
-1.8451
Nonoperating Income/Loss
0.0912
-
Income/Loss From Continuing Operations Before Tax
23.95%
-2.2561
-1.8201
Income/Loss From Continuing Operations After Tax
23.95%
-2.2561
-1.8201
Net Income/Loss
23.95%
-2.2561
-1.8201
Preferred Stock Dividends And Other Adjustments
-
-
Attributable To Noncontrolling Interest
-
-
Basic Average Shares
32.01%
11.76
17.29
Diluted Average Shares
32.01%
11.76
17.29
Basic Earnings Per Share
72.73%
-0.19
-0.11
Diluted Earnings Per Share
72.73%
-0.19
-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
-
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Kapitalisierung:     |  Volumen (24h):